Table of Content

1 Study Coverage
1.1 Dermal Fillers and Botulinum Toxin Product Introduction
1.2 Market by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type
1.4.2 Dermal Fillers
1.4.3 Botulinum Toxin
1.3 Market by Application
1.3.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application
1.3.2 Medical
1.3.3 Cosmetic
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Dermal Fillers and Botulinum Toxin Sales Estimates and Forecasts 2016-2027
2.2 Global Dermal Fillers and Botulinum Toxin Revenue Estimates and Forecasts 2016-2027
2.3 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales
2.4.1 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales (2016-2021)
2.4.2 Global Top Dermal Fillers and Botulinum Toxin Regions by Sales (2022-2027)
2.5 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue
2.5.1 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue (2016-2021)
2.5.2 Global Top Dermal Fillers and Botulinum Toxin Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dermal Fillers and Botulinum Toxin Sales by Manufacturers
3.1.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Sales (2016-2021)
3.1.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Dermal Fillers and Botulinum Toxin Sales in 2020
3.2 Global Dermal Fillers and Botulinum Toxin Revenue by Manufacturers
3.2.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Dermal Fillers and Botulinum Toxin Revenue in 2020
3.3 Global Dermal Fillers and Botulinum Toxin Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dermal Fillers and Botulinum Toxin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Dermal Fillers and Botulinum Toxin Sales by Type
4.1.1 Global Dermal Fillers and Botulinum Toxin Historical Sales by Type (2016-2021)
4.1.2 Global Dermal Fillers and Botulinum Toxin Forecasted Sales by Type (2022-2027)
4.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
4.2 Global Dermal Fillers and Botulinum Toxin Revenue by Type
4.2.1 Global Dermal Fillers and Botulinum Toxin Historical Revenue by Type (2016-2021)
4.2.2 Global Dermal Fillers and Botulinum Toxin Forecasted Revenue by Type (2022-2027)
4.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
4.3 Global Dermal Fillers and Botulinum Toxin Price by Type
4.3.1 Global Dermal Fillers and Botulinum Toxin Price by Type (2016-2021)
4.3.2 Global Dermal Fillers and Botulinum Toxin Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Dermal Fillers and Botulinum Toxin Sales by Application
5.1.1 Global Dermal Fillers and Botulinum Toxin Historical Sales by Application (2016-2021)
5.1.2 Global Dermal Fillers and Botulinum Toxin Forecasted Sales by Application (2022-2027)
5.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
5.2 Global Dermal Fillers and Botulinum Toxin Revenue by Application
5.2.1 Global Dermal Fillers and Botulinum Toxin Historical Revenue by Application (2016-2021)
5.2.2 Global Dermal Fillers and Botulinum Toxin Forecasted Revenue by Application (2022-2027)
5.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
5.3 Global Dermal Fillers and Botulinum Toxin Price by Application
5.3.1 Global Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)
5.3.2 Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027)

6 North America
6.1 North America Dermal Fillers and Botulinum Toxin Market Size by Type
6.1.1 North America Dermal Fillers and Botulinum Toxin Sales by Type (2016-2027)
6.1.2 North America Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2027)
6.2 North America Dermal Fillers and Botulinum Toxin Market Size by Application
6.2.1 North America Dermal Fillers and Botulinum Toxin Sales by Application (2016-2027)
6.2.2 North America Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2027)
6.3 North America Dermal Fillers and Botulinum Toxin Market Size by Country
6.3.1 North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2027)
6.3.2 North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dermal Fillers and Botulinum Toxin Market Size by Type
7.1.1 Europe Dermal Fillers and Botulinum Toxin Sales by Type (2017-2027)
7.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Type (2017-2027)
7.2 Europe Dermal Fillers and Botulinum Toxin Market Size by Application
7.2.1 Europe Dermal Fillers and Botulinum Toxin Sales by Application (2017-2027)
7.2.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Application (2017-2027)
7.3 Europe Dermal Fillers and Botulinum Toxin Market Size by Country
7.3.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2017-2027)
7.3.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Type
8.1.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2018-2027)
8.1.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Type (2018-2027)
8.2 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Application
8.2.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2018-2027)
8.2.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Application (2018-2027)
8.3 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size by Region
8.3.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2018-2027)
8.3.2 Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dermal Fillers and Botulinum Toxin Market Size by Type
9.1.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2027)
9.1.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Type (2019-2027)
9.2 Latin America Dermal Fillers and Botulinum Toxin Market Size by Application
9.2.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2027)
9.2.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Application (2019-2027)
9.3 Latin America Dermal Fillers and Botulinum Toxin Market Size by Country
9.3.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2027)
9.3.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Type
6.1.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2016-2027)
6.1.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2027)
6.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Application
6.2.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2016-2027)
6.2.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2027)
6.3 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size by Country
6.3.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2027)
6.3.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Description
11.1.5 Allergan Related Developments
11.2 Galderma
11.2.1 Galderma Corporation Information
11.2.2 Galderma Overview
11.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Galderma Dermal Fillers and Botulinum Toxin Product Description
11.2.5 Galderma Related Developments
11.3 LG Life Science
11.3.1 LG Life Science Corporation Information
11.3.2 LG Life Science Overview
11.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Product Description
11.3.5 LG Life Science Related Developments
11.4 Merz
11.4.1 Merz Corporation Information
11.4.2 Merz Overview
11.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Merz Dermal Fillers and Botulinum Toxin Product Description
11.4.5 Merz Related Developments
11.5 Medytox
11.5.1 Medytox Corporation Information
11.5.2 Medytox Overview
11.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Medytox Dermal Fillers and Botulinum Toxin Product Description
11.5.5 Medytox Related Developments
11.6 Bloomage
11.6.1 Bloomage Corporation Information
11.6.2 Bloomage Overview
11.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Bloomage Dermal Fillers and Botulinum Toxin Product Description
11.6.5 Bloomage Related Developments
11.7 Bohus BioTech
11.7.1 Bohus BioTech Corporation Information
11.7.2 Bohus BioTech Overview
11.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Description
11.7.5 Bohus BioTech Related Developments
11.8 Sinclair Pharma
11.8.1 Sinclair Pharma Corporation Information
11.8.2 Sinclair Pharma Overview
11.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Description
11.8.5 Sinclair Pharma Related Developments
11.9 IMEIK
11.9.1 IMEIK Corporation Information
11.9.2 IMEIK Overview
11.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 IMEIK Dermal Fillers and Botulinum Toxin Product Description
11.9.5 IMEIK Related Developments
11.10 Suneva Medical
11.10.1 Suneva Medical Corporation Information
11.10.2 Suneva Medical Overview
11.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Product Description
11.10.5 Suneva Medical Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Allergan Dermal Fillers and Botulinum Toxin Product Description
11.1.5 Allergan Related Developments
11.12 Luminera
11.12.1 Luminera Corporation Information
11.12.2 Luminera Overview
11.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Luminera Product Description
11.12.5 Luminera Related Developments
11.13 SciVision Biotech
11.13.1 SciVision Biotech Corporation Information
11.13.2 SciVision Biotech Overview
11.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 SciVision Biotech Product Description
11.13.5 SciVision Biotech Related Developments
11.14 Haohai Bio
11.14.1 Haohai Bio Corporation Information
11.14.2 Haohai Bio Overview
11.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Haohai Bio Product Description
11.14.5 Haohai Bio Related Developments
11.15 Ipsen
11.15.1 Ipsen Corporation Information
11.15.2 Ipsen Overview
11.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Ipsen Product Description
11.15.5 Ipsen Related Developments
11.16 LIBP
11.16.1 LIBP Corporation Information
11.16.2 LIBP Overview
11.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 LIBP Product Description
11.16.5 LIBP Related Developments
11.17 US World Meds
11.17.1 US World Meds Corporation Information
11.17.2 US World Meds Overview
11.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 US World Meds Product Description
11.17.5 US World Meds Related Developments
11.18 Hugel
11.18.1 Hugel Corporation Information
11.18.2 Hugel Overview
11.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 Hugel Product Description
11.18.5 Hugel Related Developments
11.19 Daewoong
11.19.1 Daewoong Corporation Information
11.19.2 Daewoong Overview
11.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Price, Revenue and Gross Margin (2016-2021)
11.19.4 Daewoong Product Description
11.19.5 Daewoong Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Dermal Fillers and Botulinum Toxin Value Chain Analysis
12.2 Dermal Fillers and Botulinum Toxin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dermal Fillers and Botulinum Toxin Production Mode & Process
12.4 Dermal Fillers and Botulinum Toxin Sales and Marketing
12.4.1 Dermal Fillers and Botulinum Toxin Sales Channels
12.4.2 Dermal Fillers and Botulinum Toxin Distributors
12.5 Dermal Fillers and Botulinum Toxin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dermal Fillers and Botulinum Toxin Industry Trends
13.2 Dermal Fillers and Botulinum Toxin Market Drivers
13.3 Dermal Fillers and Botulinum Toxin Market Challenges
13.4 Dermal Fillers and Botulinum Toxin Market Restraints

14 Key Findings in The Global Dermal Fillers and Botulinum Toxin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dermal Fillers
Table 3. Major Manufacturers of Botulinum Toxin
Table 4. Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 7. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 8. Global Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 9. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2022-2027)
Table 10. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
Table 12. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2022-2027)
Table 14. Global Dermal Fillers and Botulinum Toxin Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Dermal Fillers and Botulinum Toxin Sales Share by Manufacturers (2016-2021)
Table 16. Global Dermal Fillers and Botulinum Toxin Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturers (2016-2021)
Table 18. Dermal Fillers and Botulinum Toxin Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2020)
Table 21. Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dermal Fillers and Botulinum Toxin Product Offered
Table 23. Date of Manufacturers Enter into Dermal Fillers and Botulinum Toxin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 26. Global Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 27. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2016-2021)
Table 28. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2022-2027)
Table 29. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2016-2021)
Table 32. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2022-2027)
Table 33. Dermal Fillers and Botulinum Toxin Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Dermal Fillers and Botulinum Toxin Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 36. Global Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 37. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2016-2021)
Table 38. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2022-2027)
Table 39. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2016-2021)
Table 42. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2022-2027)
Table 43. Dermal Fillers and Botulinum Toxin Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 46. North America Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 47. North America Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 50. North America Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 51. North America Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 54. North America Dermal Fillers and Botulinum Toxin Sales by Country (2022-2027) & (K Units)
Table 55. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 58. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 59. Europe Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 62. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 63. Europe Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 66. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2022-2027) & (K Units)
Table 67. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2022-2027) & (US$ Million)
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Major Businesses
Table 107. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Allergan Dermal Fillers and Botulinum Toxin Product
Table 109. Allergan Recent Developments
Table 110. Galderma Corporation Information
Table 111. Galderma Description and Major Businesses
Table 112. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Galderma Dermal Fillers and Botulinum Toxin Product
Table 114. Galderma Recent Developments
Table 115. LG Life Science Corporation Information
Table 116. LG Life Science Description and Major Businesses
Table 117. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. LG Life Science Dermal Fillers and Botulinum Toxin Product
Table 119. LG Life Science Recent Developments
Table 120. Merz Corporation Information
Table 121. Merz Description and Major Businesses
Table 122. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Merz Dermal Fillers and Botulinum Toxin Product
Table 124. Merz Recent Developments
Table 125. Medytox Corporation Information
Table 126. Medytox Description and Major Businesses
Table 127. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Medytox Dermal Fillers and Botulinum Toxin Product
Table 129. Medytox Recent Developments
Table 130. Bloomage Corporation Information
Table 131. Bloomage Description and Major Businesses
Table 132. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Bloomage Dermal Fillers and Botulinum Toxin Product
Table 134. Bloomage Recent Developments
Table 135. Bohus BioTech Corporation Information
Table 136. Bohus BioTech Description and Major Businesses
Table 137. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Bohus BioTech Dermal Fillers and Botulinum Toxin Product
Table 139. Bohus BioTech Recent Developments
Table 140. Sinclair Pharma Corporation Information
Table 141. Sinclair Pharma Description and Major Businesses
Table 142. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product
Table 144. Sinclair Pharma Recent Developments
Table 145. IMEIK Corporation Information
Table 146. IMEIK Description and Major Businesses
Table 147. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. IMEIK Dermal Fillers and Botulinum Toxin Product
Table 149. IMEIK Recent Developments
Table 150. Suneva Medical Corporation Information
Table 151. Suneva Medical Description and Major Businesses
Table 152. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Suneva Medical Dermal Fillers and Botulinum Toxin Product
Table 154. Suneva Medical Recent Developments
Table 155. Teoxane Corporation Information
Table 156. Teoxane Description and Major Businesses
Table 157. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Teoxane Dermal Fillers and Botulinum Toxin Product
Table 159. Teoxane Recent Developments
Table 160. Luminera Corporation Information
Table 161. Luminera Description and Major Businesses
Table 162. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Luminera Dermal Fillers and Botulinum Toxin Product
Table 164. Luminera Recent Developments
Table 165. SciVision Biotech Corporation Information
Table 166. SciVision Biotech Description and Major Businesses
Table 167. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. SciVision Biotech Dermal Fillers and Botulinum Toxin Product
Table 169. SciVision Biotech Recent Developments
Table 170. Haohai Bio Corporation Information
Table 171. Haohai Bio Description and Major Businesses
Table 172. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Haohai Bio Dermal Fillers and Botulinum Toxin Product
Table 174. Haohai Bio Recent Developments
Table 175. Ipsen Corporation Information
Table 176. Ipsen Description and Major Businesses
Table 177. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Ipsen Dermal Fillers and Botulinum Toxin Product
Table 179. Ipsen Recent Developments
Table 180. LIBP Corporation Information
Table 181. LIBP Description and Major Businesses
Table 182. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. LIBP Dermal Fillers and Botulinum Toxin Product
Table 184. LIBP Recent Developments
Table 185. US World Meds Corporation Information
Table 186. US World Meds Description and Major Businesses
Table 187. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 188. US World Meds Dermal Fillers and Botulinum Toxin Product
Table 189. US World Meds Recent Developments
Table 190. Hugel Corporation Information
Table 191. Hugel Description and Major Businesses
Table 192. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 193. Hugel Dermal Fillers and Botulinum Toxin Product
Table 194. Hugel Recent Developments
Table 195. Daewoong Corporation Information
Table 196. Daewoong Description and Major Businesses
Table 197. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 198. Daewoong Dermal Fillers and Botulinum Toxin Product
Table 199. Daewoong Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Dermal Fillers and Botulinum Toxin Distributors List
Table 203. Dermal Fillers and Botulinum Toxin Customers List
Table 204. Dermal Fillers and Botulinum Toxin Market Trends
Table 205. Dermal Fillers and Botulinum Toxin Market Drivers
Table 206. Dermal Fillers and Botulinum Toxin Market Challenges
Table 207. Dermal Fillers and Botulinum Toxin Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Fillers and Botulinum Toxin Product Picture
Figure 2. Global Dermal Fillers and Botulinum Toxin Market Share by Type in 2020 & 2027
Figure 3. Dermal Fillers Product Picture
Figure 4. Botulinum Toxin Product Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020 & 2027
Figure 6. Medical
Figure 7. Cosmetic
Figure 8. Dermal Fillers and Botulinum Toxin Report Years Considered
Figure 9. Global Dermal Fillers and Botulinum Toxin Sales 2016-2027 (K Units)
Figure 10. Global Dermal Fillers and Botulinum Toxin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dermal Fillers and Botulinum Toxin Revenue 2016-2027 (US$ Million)
Figure 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Figure 14. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2022-2027)
Figure 15. North America Dermal Fillers and Botulinum Toxin Sales YoY (2016-2027) & (K Units)
Figure 16. North America Dermal Fillers and Botulinum Toxin Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Dermal Fillers and Botulinum Toxin Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Dermal Fillers and Botulinum Toxin Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Dermal Fillers and Botulinum Toxin Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Dermal Fillers and Botulinum Toxin Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Dermal Fillers and Botulinum Toxin Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Dermal Fillers and Botulinum Toxin Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Dermal Fillers and Botulinum Toxin Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Dermal Fillers and Botulinum Toxin Revenue in 2020
Figure 27. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 29. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 30. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 31. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 32. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 33. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 34. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 35. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 36. North America Dermal Fillers and Botulinum Toxin Sales Share by Country (2016-2027)
Figure 37. North America Dermal Fillers and Botulinum Toxin Revenue Share by Country (2016-2027)
Figure 38. U.S. Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 41. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 42. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 43. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 44. Europe Dermal Fillers and Botulinum Toxin Sales Share by Country (2016-2027)
Figure 45. Europe Dermal Fillers and Botulinum Toxin Revenue Share by Country (2016-2027)
Figure 46. Germany Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 47. France Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Dermal Fillers and Botulinum Toxin Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Dermal Fillers and Botulinum Toxin Revenue Share by Region (2016-2027)
Figure 57. China Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 60. India Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 62. Taiwan Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 66. Philippines Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 68. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 70. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Dermal Fillers and Botulinum Toxin Sales Share by Country (2016-2027)
Figure 72. Latin America Dermal Fillers and Botulinum Toxin Revenue Share by Country (2016-2027)
Figure 73. Mexico Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Share by Country (2016-2027)
Figure 82. Turkey Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 84. U.A.E Dermal Fillers and Botulinum Toxin Revenue (2016-2027) & (US$ Million)
Figure 85. Dermal Fillers and Botulinum Toxin Value Chain
Figure 86. Dermal Fillers and Botulinum Toxin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed